Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

A Double-blind, Randomized Trial Examining the Preliminary Efficacy of Psilocybin Therapy for People With Chronic Low Back Pain

To see complete record on, please visit this link

Id: NCT05351541

Organisation Name: University of California, San Francisco

Overal Status: Not yet recruiting

Start Date: January 2023

Last Update: October 27, 2022

Lead Sponsor: Joshua Woolley, MD/PhD

Brief Summary: This study evaluates whether psilocybin therapy helps patients cope with chronic low back pain more effectively. Patients may be recruited at Stanford and University of California San Francisco (UCSF), study procedures will occur at UCSF. Each participant will receive a dose of psilocybin with possibly one or more other drugs. Participants will undergo two preparation sessions, a dosing session, three integration sessions to discuss their psilocybin experience, and several follow up sessions.

  • Chronic Low-back Pain

Total execution time in seconds: 0.19995617866516